Anatara Lifesciences Ltd (AU:ANR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Anatara Lifesciences Limited has announced a change in the director’s interests, with John Michailidis acquiring 359,640 performance rights following shareholder approval at their recent AGM. This update indicates potential strategic moves within the company that may interest investors watching director activities closely.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.